<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The gut-specific homeotic transcription factor Cdx2 is a crucial regulator of intestinal development and homeostasis, which is downregulated in <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) and exhibits a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor function in the colon </plain></SENT>
<SENT sid="1" pm="."><plain>We have previously established that several endodermal transcription factors, including HNF4α and GATA6, are involved in Cdx2 regulation in the <z:mpath ids='MPATH_458'>normal</z:mpath> gut </plain></SENT>
<SENT sid="2" pm="."><plain>Here we have studied the role of HNF4α in the mechanism of deregulation of Cdx2 in <z:hpo ids='HP_0003003'>colon cancers</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Crossing Apc(Δ14/+) mice prone to spontaneous <z:e sem="disease" ids="C0021841" disease_type="Neoplastic Process" abbrv="">intestinal tumor</z:e> development with pCdx2-9LacZ transgenic mice containing the LacZ reporter under the control of the 9.3-kb Cdx2 promoter showed that this promoter segment contains sequences recapitulating the decrease of Cdx2 expression in <z:e sem="disease" ids="C0346627" disease_type="Neoplastic Process" abbrv="">intestinal cancers</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Immunohistochemistry revealed that HNF4α, unlike GATA6, exhibited a similar decrease to Cdx2 in genetic (Apc(min/+) and Apc(Δ14/+)) and chemically induced (Azoxymethane (AOM) treatment) models of <z:e sem="disease" ids="C0021841" disease_type="Neoplastic Process" abbrv="">intestinal tumors</z:e> in mice </plain></SENT>
<SENT sid="5" pm="."><plain>HNF4α and Cdx2 also exhibited a comparable deregulated pattern in human <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Correlated patterns were observed between HNF4α and Cdx2 in several experimental models of human <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cell lines: xenografts in <z:mp ids='MP_0003815'>nude</z:mp> mice, wound healing and <z:chebi fb="105" ids="17234">glucose</z:chebi> starvation </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, Cdx2 decreased by knocking down HNF4α in human <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells using siRNA and in the colon of mice conditionally knocked out for the Hnf4α gene in the adult intestine (Hnf4α(f/f);VilCre(ERT2) mice) </plain></SENT>
<SENT sid="8" pm="."><plain>Finally, the conditionally knocked out mice Hnf4α(f/f);VilCre(ERT2) treated with the carcinogen AOM developed <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> earlier than <z:mp ids='MP_0002169'>wild-type</z:mp> mice, as previously reported for mice with a reduced Cdx2 expression </plain></SENT>
<SENT sid="9" pm="."><plain>In conclusion, this study provides evidence that the downregulation of HNF4α is an important determinant of the reduced expression of the Cdx2 <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene in <z:e sem="disease" ids="C0346627" disease_type="Neoplastic Process" abbrv="">intestinal cancers</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Consistently, similar to Cdx2, HNF4α exerts a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor function in the colon in that its loss of function facilitates <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e>.Oncogene advance online publication, 17 September 2012; doi:10.1038/onc.2012.401 </plain></SENT>
</text></document>